How Sanofi ' s Setback Could Lead to Better Dengue Vaccines How Sanofi ' s Setback Could Lead to Better Dengue Vaccines

New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi ' s Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news